Phase II trial of reovirus as neoadjuvant therapy in patients with metastatic colorectal cancer.
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2012
At a glance
- Drugs Pelareorep (Primary)
- Indications Cancer metastases; Colorectal cancer
- Focus Therapeutic Use
- 13 Jun 2012 Final results were published in the journal Science Translational Medicine, according to an Oncolytics Biotech media release.
- 20 Apr 2011 Final results are expected in 2011, according to a Oncolytics Biotech media release.
- 20 Apr 2011 Interim results from 10 patients reported in a Oncolytics Biotech media release.